Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
Age
2–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient has a diagnosis of Atopic Dermatitis rated mild using the Investigator's Global Atopic Dermatitis Assessment involving a minimum of 5% of the body surface area, and the maximum of 20% of the body surface area
If female, and of childbearing potential, patient has a negative pregnancy test and agrees to practice effective birth control during the study
You may not be if
Patient has a skin disorder other than Atopic Dermatitis in the areas to be treated
Patient has extensive scarring or pigmented lesions in the areas to be treated that would interfere with rating of efficacy parameters
Patient has clinically infected Atopic Dermatitis at baseline
Patient is likely to require systemic corticosteroids, or the patient is likely to require intranasal or inhaled corticosteroids for an off-label indication or at higher doses than the maximum labeled dosing for the drug
Patient has a known hypersensitivity to macrolides or any excipient of either study medication
Patient has a chronic condition which is either not stable or not well controlled
Patient is pregnant or breast feeding an infant
Clareo Health | Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
